Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III).

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Curr Bladder Dysfunct Rep (2010) 1.74

Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia. Korean J Urol (2014) 1.74

Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume. BJU Int (2012) 1.52

Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration--results from the BACH Survey. J Urol (2008) 1.49

A systematic evaluation of factors associated with nocturia--the population-based FINNO study. Am J Epidemiol (2009) 1.29

Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston Area Community Health Survey. J Urol (2009) 1.18

Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int (2007) 1.07

Urological aspects of the metabolic syndrome. Nat Rev Urol (2011) 1.06

A study of bladder dysfunction in women with type 2 diabetes mellitus. Indian J Endocrinol Metab (2014) 1.03

Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. Int J Endocrinol (2014) 1.01

Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. Urology (2007) 0.99

Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention. Korean J Urol (2011) 0.98

Effect of obesity on prostate-specific antigen, prostate volume, and international prostate symptom score in patients with benign prostatic hyperplasia. Korean J Urol (2011) 0.98

Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. BJU Int (2010) 0.96

Effects of obesity on prostate volume and lower urinary tract symptoms in korean men. Korean J Urol (2010) 0.94

Correlation between Metabolic Syndrome and Lower Urinary Tract Symptoms of Males and Females in the Aspect of Gender-Specific Medicine: A Single Institutional Study. Korean J Urol (2010) 0.94

Relationship between metabolic syndrome and prostate volume in Korean men under 50 years of age. Korean J Urol (2011) 0.93

Late-onset hypogonadism syndrome and lower urinary tract symptoms. Korean J Urol (2011) 0.91

The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome. World J Urol (2015) 0.91

Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate (2009) 0.89

Association between components of metabolic syndrome and prostatic enlargement: An Indian perspective. Med J Armed Forces India (2016) 0.87

Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int (2011) 0.86

Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol (2013) 0.84

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol (2016) 0.84

Insulin relaxes bladder via PI3K/AKT/eNOS pathway activation in mucosa: unfolded protein response-dependent insulin resistance as a cause of obesity-associated overactive bladder. J Physiol (2013) 0.82

Lower urinary tract symptoms and diet quality: findings from the 2000-2001 National Health and Nutrition Examination Survey. Urology (2012) 0.82

Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area. Korean J Urol (2015) 0.80

Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra? PLoS One (2013) 0.79

Alterations in peripheral purinergic and muscarinic signaling of rat bladder after long-term fructose-induced metabolic syndrome. Eur J Nutr (2012) 0.79

Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study. World J Urol (2014) 0.79

Does Metabolic Syndrome or its Components Correlate With Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients? Nephrourol Mon (2015) 0.78

Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis. World J Urol (2015) 0.78

Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer. Int J Cancer (2016) 0.77

AMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis. Sci Rep (2016) 0.77

Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice. PLoS One (2012) 0.77

Hyperglycemia, hyperinsulinemia, insulin resistance, and the risk of BPH/LUTS severity and progression over time in community dwelling black men: the Flint Men's Health Study. Urology (2013) 0.77

Relationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study. Biomed Res Int (2015) 0.76

Sexual health as a portal to men's health: a problem turned around into an opportunity. Int J Clin Pract (2008) 0.76

Are blood vessels a target to treat lower urinary tract dysfunction? Naunyn Schmiedebergs Arch Pharmacol (2015) 0.76

Coining a new term-Urovesicology: advancing towards a mechanistic understanding of bladder symptoms. Transl Androl Urol (2012) 0.75

Alteration of loperamide-induced prostate relaxation in high-fat diet-fed rats. ScientificWorldJournal (2014) 0.75

Association of Functional Ability and Benign Prostatic Hyperplasia With Urinary Incontinence in Older Korean Men. Int Neurourol J (2016) 0.75

Association between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men. Asian J Androl (2015) 0.75

Effect of obesity on International Prostate Symptom Score and prostate volume. Urol Ann (2015) 0.75

Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-Up. PLoS One (2016) 0.75

Metabolic syndrome does not impair the response to alfuzosin treatment in men with lower urinary tract symptoms: a double-blind, randomized, placebo-controlled study. Turk J Urol (2015) 0.75

Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (1998) 6.50

Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med (1993) 6.37

Epidemic influenza and vitamin D. Epidemiol Infect (2006) 5.32

Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst (1999) 5.27

Race/ethnicity, social class and their relation to physical inactivity during leisure time: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Prev Med (2000) 4.73

Reproducibility and validity of a self-administered physical activity questionnaire for male health professionals. Epidemiology (1996) 4.37

Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30

Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA (1996) 4.29

Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89

Recreational physical activity and the risk of cholecystectomy in women. N Engl J Med (1999) 3.82

Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am J Epidemiol (1995) 3.76

Television watching, energy intake, and obesity in US children: results from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med (2001) 3.63

Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res (1997) 3.36

A prospective study of social networks in relation to total mortality and cardiovascular disease in men in the USA. J Epidemiol Community Health (1996) 3.28

Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst (1999) 3.22

Alcohol intake in relation to diet and obesity in women and men. Am J Clin Nutr (1991) 3.20

Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst (1998) 2.97

Acculturation and leisure-time physical inactivity in Mexican American adults: results from NHANES III, 1988-1994. Am J Public Health (2001) 2.88

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts. Am J Clin Nutr (2000) 2.61

Adiposity and mortality in men. Am J Epidemiol (2000) 2.60

Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst (1996) 2.58

Coffee, caffeine, and cardiovascular disease in men. N Engl J Med (1990) 2.49

Leisure-time physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst (1997) 2.46

A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol (1991) 2.45

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res (1999) 2.30

Detection and characterization of broad-host-range plasmids in environmental bacteria by PCR. Appl Environ Microbiol (1996) 2.14

A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev (2000) 2.12

Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation (1994) 2.10

British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05

A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res (1996) 2.03

Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med (1998) 1.96

Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90

Clinical characteristics of paediatric H1N1 admissions in Birmingham, UK. Lancet (2009) 1.87

Diet and basal cell carcinoma of the skin in a prospective cohort of men. Am J Clin Nutr (2000) 1.85

Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control (2000) 1.82

Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol (1990) 1.78

Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol (1998) 1.76

Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol (1999) 1.73

Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals. J Natl Cancer Inst (2000) 1.72

Benefit-risk assessment of vitamin D supplementation. Osteoporos Int (2009) 1.70

A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health (2000) 1.68

Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41. Antimicrob Agents Chemother (2005) 1.63

A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control (2001) 1.62

Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol (1999) 1.58

Estimating the global and regional burden of suboptimal nutrition on chronic disease: methods and inputs to the analysis. Eur J Clin Nutr (2011) 1.54

Harvard Report on Cancer Prevention. Volume 3: prevention of colon cancer in the United States. Cancer Causes Control (1999) 1.51

A prospective study of coffee consumption and the risk of symptomatic gallstone disease in men. JAMA (1999) 1.51

Prevalence of physical inactivity and its relation to social class in U.S. adults: results from the Third National Health and Nutrition Examination Survey, 1988-1994. Med Sci Sports Exerc (1999) 1.50

Predictors of dietary heterocyclic amine intake in three prospective cohorts. Cancer Epidemiol Biomarkers Prev (1998) 1.49

Body weight and colorectal cancer risk in a cohort of Swedish women: relation varies by age and cancer site. Br J Cancer (2001) 1.49

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev (2000) 1.43

Selected vitamins in HIV infection: a review. AIDS Patient Care STDS (1998) 1.42

Cloning the breakpoint cluster region of the inv(16) in acute nonlymphocytic leukemia M4 Eo. Hum Mol Genet (1993) 1.40

Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians. Cancer Epidemiol Biomarkers Prev (1998) 1.39

Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer (2005) 1.39

Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol (1996) 1.37

Blood donations and risk of coronary heart disease in men. Circulation (2001) 1.36

High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med (1998) 1.32

A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev (1999) 1.31

Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men. Cancer Epidemiol Biomarkers Prev (1999) 1.30

Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men. J Natl Cancer Inst (2001) 1.29

Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev (2001) 1.28

Physical activity and benign prostatic hyperplasia. Arch Intern Med (1998) 1.27

Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol (2000) 1.26

Dairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden) Cancer Causes Control (1998) 1.25

Inducible gene expression mediated by a repressor-operator system isolated from Lactococcus lactis bacteriophage r1t. Mol Microbiol (1996) 1.25

Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control (1995) 1.25

Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer (1996) 1.24

Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer (2010) 1.19

Calcium, vitamin D, dairy foods, and the occurrence of colorectal adenomas among men and women in two prospective studies. Am J Epidemiol (1994) 1.19

A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.18

Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol (2000) 1.16

Analysis of the dynamics of fungal communities in soil via fungal-specific PCR of soil DNA followed by denaturing gradient gel electrophoresis. J Microbiol Methods (2000) 1.16

Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med (1999) 1.16

A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis (1998) 1.15

Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis. Scand J Infect Dis (2001) 1.08

Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control (1999) 1.08

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br J Cancer (2011) 1.07

Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the Health Professionals Follow-up Study. Urology (1998) 1.01

Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol (1999) 1.01

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010. HIV Med (2010) 1.00

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia. Urology (1999) 1.00

Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev (1997) 1.00

A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men. Growth Horm IGF Res (2000) 1.00

Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer (2003) 0.99

Objectively measured physical activity and C-reactive protein: National Health and Nutrition Examination Survey 2003-2004. Scand J Med Sci Sports (2011) 0.99

Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer. Br J Cancer (2010) 0.99

The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol (2001) 0.98

Gallstones, cholecystectomy, and the risk for developing pancreatic cancer. Br J Cancer (2002) 0.98

Diet, nutrition, and prostate cancer. Annu Rev Nutr (1998) 0.98

Reverse chromosome painting for the identification of marker chromosomes and complex translocations in leukemia. Cytometry (1999) 0.98

Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer. Cancer Causes Control (2010) 0.98

The early bactericidal activity of amikacin in pulmonary tuberculosis. Int J Tuberc Lung Dis (2001) 0.97

Characterization of Treponema pallidum particle agglutination assay-negative sera following screening by treponemal total antibody enzyme immunoassays. Clin Vaccine Immunol (2010) 0.96

Aspirin use and lung cancer in men. Br J Cancer (2003) 0.95

Translocation of BCR to chromosome 9: a new cytogenetic variant detected by FISH in two Ph-negative, BCR-positive patients with chronic myeloid leukemia. Genes Chromosomes Cancer (1993) 0.95

Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer (2006) 0.95